KernerW,BrückelJ.,Definition,,2014,Classification and diagnosis of diabetes mellitus,Exp Clin Endocrinol Diabetes,122,384-6
MeoSA,ZiaI,BukhariIA,ArainSA,,2016,Type 2 diabetes mellitus in Pakistan: current prevalence and future forecast,J Pak Med Assoc,66,1637-42
Waugh J, Keating GM, Plosker GL, Easthope S, Robinson DM.
Pioglitazone a review of its use in type 2 diabetes mellitus. Drugs
2006;66:85–109.
Gutiérrez-Rodelo C, Roura-Guiberna A, Olivares-Reyes JA.
Molecular mechanisms of insulin resistance: An update. Gac
Med Mex 2017;153:214–28.
JiangZ,ZhouJ,ZhouD,ZhuZ,SunL,NanjiAA,,2015,The adiponectin-SIRT1-AMPK pathway in alcoholic fatty liver disease in the rat,Alcohol Clin Exp Res,39,424-33
Schofield JD, Liu Y, Rao-Balakrishna P, Malik RA, Soran H.
Diabetes dyslipidemia. Diabetes Ther 2016;7:203–19.
SchaalanMF,,2012,Effects of pioglitazone and/or simvastatin on circulating TNFα and adiponectin levels in insulin resistance,J. Immunotoxicol,9,201-9
AghamohammadzadehN,NiafarM,Dali AbdolahiniaE,NajafipourF,GharebaghiSM,AdabiK,,2015,The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients,Ther Adv Endocrinol Metab,6,56-60
LongoN,FrigeniM,PasqualiM.,,1863,Carnitine transport and fatty acid oxidation,Biochim Biophys Acta,,2422-35
XiaY,LiQ,ZhongW,DongJ,WangZ,WangC.,,2011,L-carnitine ameliorated fatty liver in high calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function,Diabetol Metab Syndr,3,31-
GilbertER,FuZ,LiuD.,,2011,Development of a non genetic mouse model of type 2 diabetes,Exp Diabetes Res,,416254-
ChinCY,MonackDM,Nathan S,,2012,Delayed activation of host innate immune pathways in streptozotocin-induced diabetic hosts leads to more severe disease during infection with Burkholderia pseudomallei,Immunology,135,312-32
OribeJ,KakumaT,HaranakaM,OkamotoK,SeikeM,Yoshimatsu H,,2012,Intreperitonial administration attenuates thiazolidinedione-induced hepatic steatosis in KKAy mice with increased hepatic peroxisome proliferator-activated receptor (PPAR)γ mRNA expression,Obes Res Clin Prac,6,e249-61
Al-HashemF,IbrahimI,BastawyN,RatebM,HaidaraM,DallakM,,2011,Effect of insulin on adiponectin and adiponectin receptor-1 expression in rats with streptozotocin induced type 2 diabetes,J Health Sci,57,334-40
KubotaN,TerauchiY,KubotaT,KumagaiH,ItohS,YanoW,Pathways,,2006,Pioglitazone Ameliorates Insulin Resistance and Diabetes by Both Adiponectin-dependent and,J Biol Chem,281,8748-55
AlshammariNM,,2011,The effects of L-carnitine and physical activity on adipocytokines and lipid profile on obese women,World J Sport Sci,4,21-4
SrinivasanK,ViswanadB,AsratL,KaulCL,RamaraoP,,2005,Combination of high-fat diet-fed and low-dose streptozotocintreated rat: A model for type 2 diabetes and pharmacological screening,Pharmacol Res,52,313-20
ChangCY,ChenMJ,YangWS,YehCY,HoHN,ChenSU,,2012,Hypoadiponectinemia: A useful marker of dyslipidemia in women with polycystic ovary syndrome,Taiwan J Obstet Gynecol,51,583-90
DurraniS,ShahJ,KhanMA,JanMR,,2014,Hypoadiponectinemia and dyslipidemia in relation to glycemic status in type 2 diabetes and coronary heart disease,Khyber Med Univ J,6,157-62
Betteridge DJ,,2007,Effects of pioglitazone on lipid and lipoprotein metabolism,Diabetes Obese Metab,9,640-7
KadowakiT,YamauchiT,KubotaN,HaraK,UekiK,TobeK.,,2006,Adiponectin and adiponectin receptors in insulin resistance, diabetes, and metabolic syndrome,J Clin Invest,116,1784-92
SamS,HaffnerS,DavidsonMH,D'AgostinoR,PerezA,MazzoneT,,2012,Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in Type 2 Diabetes,J Clin Endocrinol Metab,97,110-4
MishraS,SinghRB,,2010,Effect of mushroom on lipid profile, lipid peroxidation and liver functions of aging swiss albino rats,Nutraceuticals J,3,248-53